Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15- Crohn's disease patients

European Journal of Human Genetics

Volumn 17, Issue 10, 2009, Pages 1304-1308

  Márquez, Ana ^a   Varadé, Jezabel ^a   Robledo, Gema ^b   Martínez, Alfonso ^a   Mendoza, Juan Luis ^a   Taxonera, Carlos ^a   Fernández Arquero, Miguel ^a   Díaz Rubio, Manuel ^a   Gómez García, María ^c   López Nevot, Miguel Angel ^c   de la Concha, Emilio G ^a   Martín, Javier ^b   Urcelay, Elena ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; LECTIN;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COHORT STUDIES; CROHN DISEASE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; LECTINS; LECTINS, C-TYPE; LINKAGE DISEQUILIBRIUM; MONOSACCHARIDE TRANSPORT PROTEINS; MULTIPLE SCLEROSIS; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; POLYMORPHISM, GENETIC; SPAIN;

EID: 70349630427     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.50     Document Type: Article

References (23)

1. Hugot JP, Chamaillard M, Zouali H et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
2. Ogura Y, Bonen DK, Inohara N et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
3. Herskovits AA, Auerbuch V, Portnoy DA: Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007; 3: E51.
4. Hafler DA, Compston A, Sawcer S et al: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
5. Hakonarson H, Grant SF, Bradfield JP et al: A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448: 591-594.
6. Todd JA, Walker NM, Cooper JD et al: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-864.
7. Zoledziewska M, Costa G, Pitzalis M et al: Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun 2008; 10 15-17.
8. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C: Myeloid C-type lectins in innate immunity. Nat Immunol 2006; 7 1258-1265.
9. McGreal EP, Martinez-Pomares L, Gordon S: Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004; 41: 1109-1121.
10. Franchimont D, Vermeire S, El Housni H et al: Deficient host - bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53: 987-992.
11. Pierik M, Joossens S, Van Steen K et al: Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12: 1-8.
12. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C: Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004; 112: 85-91.
13. Underhill DM: Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev 2007; 219: 75-87.
14. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6; discussion 16-19.
15. Oliver J, Marquez A, Gomez-Garcia M et al: Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007; 56: 150-151.
16. Nunez C, Rueda B, Martinez A et al: A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population. World J Gastroenterol 2006; 12: 4397-4400.
17. Nunez C, Oliver J, Mendoza JL et al: CD209 in inflammatory bowel disease: A case - control study in the Spanish population. BMC Med Genet 2007; 8: 75.
18. Chinen T, Kobayashi T, Ogata H et al: Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. Gastroenterology 2006; 130: 373-388.
19. Inagaki-Ohara K, Sasaki A, Matsuzaki G et al: Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. Gut 2006; 55: 212-219.
20. Mansell A, Smith R, Doyle SL et al: Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006; 7: 148-155.
21. Martinez A, Sanchez-Lopez M, Varade J et al: Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007; 66: 325-329.
22. Wellcome Trust Case Control Consortium: Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
23. Mathew CG: New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008; 9: 9-14.